Latest News
From the Journals
MenB vaccination coverage higher in those receiving MenB-4C
...
News from the FDA/CDC
FDA approves istradefylline for Parkinson’s disease
Guidelines
AAN guideline encourages vaccinations for MS patients
Unless there are specific contraindications, clinicians should advise patients to follow local vaccine standards, the guideline says.
Conference Coverage
A new beverage aims to make ketogenic diets more palatable
BANGKOK – Designed to be consumed with regular foods, this beverage shows preliminary evidence of an antiseizure effect.
Feature
Disputes over malpractice blame: Do allocations matter?
A legal battle between a doctor and insurer highlight conflicts that can arise when settling medical malpractice claims.
From the Journals
Prices, out-of-pocket costs for MS drugs rose despite competition
Rather than decreasing prices, the introduction of new self-administered therapies after 2009 may have contributed to increased prices.
Literature Review
Blood test may reveal brain injury
Levels of glial fibrillary acidic protein (GFAP) and ubiquitin C-terminal hydrolase L1 (UCH-L1) are lowest in patients with nonconcussive body...
From the Journals
Genotype may affect lifestyle’s influence on dementia risk
Among APOE4 carriers, health and lifestyle factors such as not smoking, being free from depression, and getting regular physical activity may not...
Conference Coverage
Intranasal midazolam as first line for status epilepticus
BANGKOK – “Time is brain,” said Dr. Lara Kay.
Conference Coverage
A practical tool predicts childhood epilepsy diagnosis
BANGKOK – The predictor is freely available online.
Conference Coverage
‘Pot’ is still hot for Dravet, Lennox-Gastaut
BANGKOK – Long-term extension studies show sustained, consistent seizure reductions.